---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-078618"
form_type: "8-K"
ticker: "PSNL"
cik: "0001527753"
company_name: "Personalis, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T00:59:30.462615+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Personalis settles patent litigation with Foresight, grants license for MRD tests, receives tiered royalties

## Summary
- Settled pending infringement claims and IPR proceedings with Foresight Diagnostics.
- Foresight gets non-exclusive license under Personalis patents for WGS-based MRD tests using phased variants.
- Foresight to pay low-single digit tiered royalty on net sales of licensed products/services.
- Upon a change of control involving specified acquirers, a low single-digit million one-time fee and slight royalty rate increase apply.
- License is perpetual except for patent challenge termination; each party releases claims and covenants not to sue on CNS patents.

## SEC filing metadata
- accession: 0000950170-24-078618
- form_type: 8-K
- ticker: PSNL
- cik: 0001527753
- company_name: Personalis, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527753/000095017024078618/0000950170-24-078618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527753/000095017024078618/psnl-20240621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-078618
- JSON: https://secwatch.observer/filing/0000950170-24-078618.json
- Plain text: https://secwatch.observer/filing/0000950170-24-078618.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.